A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood | MicrobiomeTrials← Back to trialsNCT06241560
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-05Est. Completion: 2026-08-04
Enrollment target: 20 participants Locations- Renovatio Clinical-The Woodlands-69551, The Woodlands, Texas, United States
- LTD The First Medical Center, Tbilisi, Georgia
- LTD "Aversi clinic", Tbilisi, Georgia
Other microbiome trials you might be interested in
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
Background:
Interstitial lung disease affects the tissues that aid the transfer of oxygen and carbon dioxide between th…
Research Triangle Park, United StatesEst. completion Dec 31, 2027
Idiopathic Pulmonary Fibrosis
This study is open to adults who are at least 40 years old and have idiopathic pulmonary fibrosis (IPF). People can part…
Birmingham, United StatesEst. completion Mar 11, 2027